ODC1 and ovarian neoplasm: Since ODC transcription is upregulated by the oncogenes, MYC and RAS [21,22], the association of high levels of MYC and mutant RAS in ovarian tumor cells resistant to PARP inhibitors and platinum-based chemotherapy may be mediated, at least in part, by polyamines.